Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy


Pancreatic cancer, a disease with extremely poor prognosis, has been notoriously resistant to virtually all forms of treatment. The dynamic crosstalk that occurs between tumour cells and the surrounding stroma, frequently mediated by intricate Src/FAK signalling, is increasingly recognised as a key player in pancreatic tumourigenesis, disease progression and therapeutic resistance. These important cues are fundamental for defining the invasive potential of pancreatic tumours, and several components of the Src and downstream effector signalling have been proposed as potent anticancer therapeutic targets. Consequently, numerous agents that block this complex network are being extensively investigated as potential antiinvasive and antimetastatic therapeutic agents for this disease. In this review, we will discuss the latest evidence of Src signalling in PDAC progression, fibrotic response and resistance to therapy. We will examine future opportunities for the development and implementation of more effective combination regimens, targeting key components of the oncogenic Src signalling axis, and in the context of a precision medicine-guided approach.

Type Journal
ISBN 1742-464x
Authors Parkin, A.; Man, J.; Timpson, P.; Pajic, M.
Responsible Garvan Author A/Prof Marina Pajic
Publisher Name FEBS Journal
Published Date 2019-09-30
Published Volume 286
Published Issue 18
Published Pages 3510-3539
Status Published in-print
DOI 10.1111/febs.15011
URL link to publisher's version